BGBIO / BergenBio

Biotech company based i Norway/UK
Listed on OSE

BergenBio`s Bemcentinib now in
UK financed Covid-19 studym, Fast track ACCORD.

Number og study ongoing: 15
3 big:
* ACCORD Covid-19
* Bemcentinib/Keytruda combo whit Merck i NSCLC.
* AML

9 of 15 sponsored studies.

Tecnicaly potent, whit big upside potential. Fair value at the moment 86nok. Archtic Securities.